Michael Patrick Miller
Director · PUMA BIOTECHNOLOGY, INC.
- 2025
- Jun 16, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael Patrick Miller files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alessandra Cesano - $567K in PBYI purchases and sales in the last 12 months
- Alan H. Auerbach - $364K in PBYI purchases and sales in the last 12 months
- Adrian Senderowicz - $194K in PBYI purchases and sales in the last 12 months
- Kamil Ali-Jackson - $160K in RIGL purchases and sales in the last 12 months
- Jay M. Moyes - $159K in PBYI purchases and sales in the last 12 months
- Walter H. Moos - $145K in RIGL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael Patrick Miller?
Michael Patrick Miller is a corporate insider, tracked as Director of PUMA BIOTECHNOLOGY, INC. (PBYI). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Michael Patrick Miller last file a Form 4?
The most recent primary Form 4 on record is dated 16 June 2026, one of 5 filings going back to 2025.
Has Michael Patrick Miller been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($97K) across all tracked filings.
